Site search

Pipeline

  1. HOME > 
  2. Pipeline

*This table can be scrolled horizontally

Developed product

Mechanism/target

Cancer type

Discovery

Preclinical

PI

PII

_Cell Therapy

BP2201

iPS cell-derived NKT cells

HNSCC

BP2301

HER2 CAR-T

Sarcoma
Gynecological
Tumors

_Antibody

BP1200

CD73

BP1202

CD39

BP1210

TIM3

BP1212

CD39 × TIM3

_Cancer Vaccine

GRN-1201

Tumor Associated Antigens

NSCLC

in combination with pembrolizumab

BP1209

Personalized Neoantigen

Solid Tumor

Page Top

×